NCT05592678View on ClinicalTrials.gov

δ in Dementia Clinical Trials

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Alzheimer's Disease (AD)DementiaCognitive DeclineMild Cognitivie Impairment (MCI)
Interventions
OTHER

Donepezil

Donepezil is administered as a standard of care treatment by the subject's provider.

Trial Locations (1)

78229-3900

RECRUITING

Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER